Astra Wealth Partners’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$360K Sell
6,398
-1,830
-22% -$82.5K 0.2% 69
2026
Q2
$230K Buy
8,228
+180
+2% +$5.06K 0.12% 96
2026
Q1
$230K Hold
8,048
– – 0.14% 83
2025
Q4
$318K Hold
8,048
– – 0.19% 74
2025
Q3
$284K Hold
8,048
– – 0.19% 73
2025
Q2
$264K Hold
8,048
– – 0.2% 72
2025
Q1
$260K Hold
8,048
– – 0.24% 63
2024
Q4
$246K Buy
+8,048
New +$259K 0.23% 63

Other funds holding ATRC

Astra Wealth Partners's ATRC Position: Q3 2026 in Review

Astra Wealth Partners reduced its AtriCure (ATRC) stake by 22% in Q3 2026, selling an estimated $82.5K and leaving 6,398 shares worth $360K. The position accounts for 0.2% of the portfolio, ranked #69.

Astra Wealth Partners first reported a position in ATRC in Q4 2024 and has held it in 8 quarters since. 120 funds tracked by Wall St. Rank hold ATRC as of Q3 2026.

  • Astra Wealth Partners held 6,398 shares of AtriCure worth $360K as of Q3 2026.
  • Astra Wealth Partners sold 1,830 AtriCure shares in Q3 2026, an estimated $82.5K.
  • AtriCure made up 0.2% of Astra Wealth Partners's portfolio in Q3 2026, its #69 holding.
  • Astra Wealth Partners first reported a position in AtriCure in Q4 2024 and has held it in 8 quarters since.
  • 120 funds tracked by Wall St. Rank held AtriCure as of Q3 2026.

Based on Astra Wealth Partners's 13F filing for Q3 2026, filed 6 Nov 2026.